Intravenous iron therapy in heart failure with preserved ejection fraction: how far have we walked?
Publication
, Journal Article
Kittipibul, V; Mentz, RJ
Published in: Eur Heart J
October 5, 2024
Duke Scholars
Published In
Eur Heart J
DOI
EISSN
1522-9645
Publication Date
October 5, 2024
Volume
45
Issue
37
Start / End Page
3801 / 3803
Location
England
Related Subject Headings
- Stroke Volume
- Iron
- Infusions, Intravenous
- Humans
- Hematinics
- Heart Failure
- Cardiovascular System & Hematology
- Anemia, Iron-Deficiency
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Kittipibul, V., & Mentz, R. J. (2024). Intravenous iron therapy in heart failure with preserved ejection fraction: how far have we walked? Eur Heart J, 45(37), 3801–3803. https://doi.org/10.1093/eurheartj/ehae490
Kittipibul, Veraprapas, and Robert J. Mentz. “Intravenous iron therapy in heart failure with preserved ejection fraction: how far have we walked?” Eur Heart J 45, no. 37 (October 5, 2024): 3801–3. https://doi.org/10.1093/eurheartj/ehae490.
Kittipibul V, Mentz RJ. Intravenous iron therapy in heart failure with preserved ejection fraction: how far have we walked? Eur Heart J. 2024 Oct 5;45(37):3801–3.
Kittipibul, Veraprapas, and Robert J. Mentz. “Intravenous iron therapy in heart failure with preserved ejection fraction: how far have we walked?” Eur Heart J, vol. 45, no. 37, Oct. 2024, pp. 3801–03. Pubmed, doi:10.1093/eurheartj/ehae490.
Kittipibul V, Mentz RJ. Intravenous iron therapy in heart failure with preserved ejection fraction: how far have we walked? Eur Heart J. 2024 Oct 5;45(37):3801–3803.
Published In
Eur Heart J
DOI
EISSN
1522-9645
Publication Date
October 5, 2024
Volume
45
Issue
37
Start / End Page
3801 / 3803
Location
England
Related Subject Headings
- Stroke Volume
- Iron
- Infusions, Intravenous
- Humans
- Hematinics
- Heart Failure
- Cardiovascular System & Hematology
- Anemia, Iron-Deficiency
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology